Eisai Co., Ltd. (TYO: 4523)
Japan
· Delayed Price · Currency is JPY
5,029.00
+72.00 (1.45%)
Nov 15, 2024, 3:45 PM JST
Eisai Revenue
Eisai had revenue of 195.99B JPY in the quarter ending September 30, 2024, with 10.97% growth. This brings the company's revenue in the last twelve months to 753.22B, down -0.80% year-over-year. In the fiscal year ending March 31, 2024, Eisai had annual revenue of 741.75B, down -0.36%.
Revenue (ttm)
753.22B
Revenue Growth
-0.80%
P/S Ratio
1.91
Revenue / Employee
68.06M
Employees
11,067
Market Cap
1,417.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 741.75B | -2.65B | -0.36% |
Mar 31, 2023 | 744.40B | -11.82B | -1.56% |
Mar 31, 2022 | 756.23B | 110.28B | 17.07% |
Mar 31, 2021 | 645.94B | -49.68B | -7.14% |
Mar 31, 2020 | 695.62B | 52.79B | 8.21% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEisai News
- 1 day ago - Eisai wins orphan drug status for Lenvima for esophageal cancer - Seeking Alpha
- 1 day ago - Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug - MarketWatch
- 1 day ago - Biogen gains as Eisai wins EU nod for Alzheimer’s drug - Seeking Alpha
- 1 day ago - EU Backs Eisai Alzheimer’s Drug Despite Earlier Rejection - BNN Bloomberg
- 4 days ago - Eisai: Still Relatively Modest Market-Implied Expectations For Leqembi - Seeking Alpha
- 4 days ago - Q2 2025 Eisai Co Ltd Earnings Presentation Transcript - GuruFocus
- 6 days ago - Eisai Co., Ltd. (ESALF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Eisai Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha